In October 2001, the National Eye Institute (NEI) one of the Federal Government's National Institutes of Health (NIH) completed a large ten-year study, the Age-Related Eye Disease Study (AREDS). AREDS proved that the formula in Viteyes can slow the progression of Macular Degeneration by 25% in people at risk of developing advanced stages of the disease. Viteyes supplies the AREDS recommended formula in only TWO daily highly soluble, easy-to-swallow capsules.

Age-related macular degeneration (AMD) is the leading cause of blindness in people over the age of 55 affecting over 6 million people in the United States. AMD is the degeneration of the central part of the retina called the macula. The macula is the part of the retina that is responsible for straight-ahead vision.